Chemical Genetics of Iron Transport
铁转运的化学遗传学
基本信息
- 批准号:7898255
- 负责人:
- 金额:$ 8.66万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-09-01 至 2010-08-31
- 项目状态:已结题
- 来源:
- 关键词:ATP phosphohydrolaseAddressAffinityAllelesAmilorideBindingBiochemicalBiological AssayBiological ProcessBiotinCaucasiansCaucasoid RaceCellsComplexCountryCytochalasin BDataDoseEmerging TechnologiesFluorescenceGene MutationGenesGenetic ScreeningGoalsHealthHereditary DiseaseHereditary hemochromatosisIndiumInhibitory Concentration 50InsulinIonsIronIron OverloadKnowledgeLabelLibrariesLiteratureMammalian CellMediatingMembrane Protein TrafficMolecularNutritionalOuabainOxidation-ReductionPathway interactionsPopulationProteinsReagentRegulationSLC11A2 geneSmall Molecule Chemical LibraryStructureStructure-Activity RelationshipTransferrinTransmembrane Transportanalogbasechemical geneticscombinatorialepithelial Na+ channelglucose uptakeinhibitor/antagonistinterestprotein functionsmall moleculesoluteuptake
项目摘要
DESCRIPTION (provided by applicant): Chemical genetics is an emerging field that takes advantage of combinatorial chemical and small molecule libraries to dissect complex biological processes. Small molecules can act very fast, can be very specific, and can help to distinguish the temporal order of molecular steps and the hierarchical regulation of biological processes. Because small molecules can alter the function of a specific gene product, they can be used in a manner analogous to the use of inducible dominant or homozygous recessive genetic mutations. A large body of biochemical literature is based on the past use of small molecule antagonists that were employed in "reverse chemical genetics" approaches to conditionally eliminate protein function, and on that basis to subsequently identify the target, its mechanism of action, and its regulation. Thus, ouabain helped to define the catalytic cycle of the NaK-ATPase, cytochalasin B was instrumental in defining the molecular basis for insulin's action to stimulate glucose uptake, and analogs of amiloride were used to purify and define the epithelial Na channel. There is a need to develop "forward chemical genetics" in order to discover small molecules that partner with key elements in a pathway of interest. This proposal is supported by preliminary data that establish a fluorescence-based assay to screen for inhibitors of iron uptake by mammalian cells. Iron deficiency remains the most prevalent nutritional problem in our country, yet recent identification of the gene responsible for hereditary hemochromatosis indicates that 1 in 20 Caucasians carry the defective allele and thus 1 in 400 may be susceptible to iron overload. Increased knowledge about the transport factors and how they protect against iron deficiency and overload is essential to more broadly address these significant health problems. Using the cell-based fluorescence assay, we propose to: 1) Perform chemical genetic screens for selective inhibitors of different pathways of iron transport using combinatorial libraries; 2) Characterize the compounds identified to block iron uptake with highest potency; 3) Develop structure-activity profiles on compounds of interest and identify their targets. The goals of this project are to discover small molecule inhibitors of iron transport using chemical genetics and to use these reagents to advance our understanding of the factors, mechanisms, and regulation of different pathways of iron uptake.
描述(由申请人提供):化学遗传学是一个新兴的领域,它利用组合化学和小分子文库来剖析复杂的生物过程。小分子可以非常快速地起作用,可以非常特异,并且可以帮助区分分子步骤的时间顺序和生物过程的分级调节。因为小分子可以改变特定基因产物的功能,所以它们可以以类似于使用诱导型显性或纯合隐性遗传突变的方式使用。大量的生物化学文献是基于过去在“反向化学遗传学”方法中采用的小分子拮抗剂的使用,以有条件地消除蛋白质功能,并在此基础上随后鉴定靶标、其作用机制及其调节。因此,哇巴因有助于确定NaK-ATP酶的催化循环,细胞松弛素B有助于确定胰岛素刺激葡萄糖摄取的分子基础,阿米洛利类似物用于纯化和确定上皮Na通道。有必要开发“正向化学遗传学”,以发现与感兴趣的途径中的关键元件合作的小分子。这一建议得到了初步数据的支持,建立了一个基于荧光的测定,以筛选哺乳动物细胞铁吸收的抑制剂。铁缺乏仍然是我国最普遍的营养问题,但最近对遗传性血色病基因的鉴定表明,每20名高加索人中就有1人携带缺陷等位基因,因此每400人中就有1人可能易患铁过载。增加对运输因素的了解以及它们如何防止铁缺乏和过载对于更广泛地解决这些重大健康问题至关重要。使用基于细胞的荧光测定,我们建议:1)使用组合文库对铁转运的不同途径的选择性抑制剂进行化学遗传筛选; 2)表征鉴定为以最高效力阻断铁摄取的化合物; 3)开发感兴趣化合物的结构-活性谱并鉴定其靶点。该项目的目标是使用化学遗传学发现铁转运的小分子抑制剂,并使用这些试剂来促进我们对铁摄取的不同途径的因素,机制和调节的理解。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Marianne Wessling-Resnick其他文献
Marianne Wessling-Resnick的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Marianne Wessling-Resnick', 18)}}的其他基金
Summer Intern Program (SIP) in Environmental Health Sciences
环境健康科学暑期实习生计划(SIP)
- 批准号:
8316246 - 财政年份:2011
- 资助金额:
$ 8.66万 - 项目类别:
Summer Intern Program (SIP) in Environmental Health Sciences
环境健康科学暑期实习生计划(SIP)
- 批准号:
8216903 - 财政年份:2011
- 资助金额:
$ 8.66万 - 项目类别:
Summer Intern Program (SIP) in Environmental Health Sciences
环境健康科学暑期实习生计划(SIP)
- 批准号:
8660697 - 财政年份:2011
- 资助金额:
$ 8.66万 - 项目类别:
Summer Intern Program (SIP) in Environmental Health Sciences
环境健康科学暑期实习生计划(SIP)
- 批准号:
8843853 - 财政年份:2011
- 资助金额:
$ 8.66万 - 项目类别:
Summer Intern Program (SIP) in Environmental Health Sciences
环境健康科学暑期实习生计划(SIP)
- 批准号:
8462276 - 财政年份:2011
- 资助金额:
$ 8.66万 - 项目类别:
HFE: A Genetic Determinant of Olfactory Mn Absorption and Toxicity
HFE:嗅觉锰吸收和毒性的遗传决定因素
- 批准号:
7941943 - 财政年份:2009
- 资助金额:
$ 8.66万 - 项目类别:
Ferristatin: A New Small Molecule Inhibitor of Iron Transport
Ferristatin:一种新的铁转运小分子抑制剂
- 批准号:
7831012 - 财政年份:2009
- 资助金额:
$ 8.66万 - 项目类别:
HFE: A Genetic Determinant of Olfactory Mn Absorption and Toxicity
HFE:嗅觉锰吸收和毒性的遗传决定因素
- 批准号:
7713292 - 财政年份:2009
- 资助金额:
$ 8.66万 - 项目类别:
Ferristatin: A New Small Molecule Inhibitor of Iron Transport
Ferristatin:一种新的铁转运小分子抑制剂
- 批准号:
7941874 - 财政年份:2009
- 资助金额:
$ 8.66万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 8.66万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 8.66万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 8.66万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 8.66万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 8.66万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 8.66万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 8.66万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 8.66万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 8.66万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 8.66万 - 项目类别:
Research Grant














{{item.name}}会员




